Blab Business
Vitalist Inc. Adds Antonio Natale to Board Following Somatix Acquisition
Vitalist Inc. (TSX‑V: VITA.V; OTCQB: VTLSF) announced on July 31, 2026 that Antonio "Tony" Natale will join its Board of Directors effective August 1, 2026. Natale will serve as a non‑independent director representing Hantz Group, a Michigan‑based financial services conglomerate, after Vitalist’s March 31 acquisition of Somatix Inc. The appointment is part of the company’s effort to integrate Somatix’s capabilities into its existing platform.
Vitalist’s CEO, Kalvie Legat, said the new director “reflects the continued integration of Somatix into Vitalist and the strategic importance of Hantz Group’s support as we advance our vision for the future of connected health.” Legat added that Natale’s background in financial advisory, capital markets, and corporate planning will strengthen the board’s financial oversight and governance.
Natale, in a statement released with the announcement, said he is “deeply passionate about the potential of smart wearables to transform personal health” and that he looks forward to working with Legat and the rest of the board to maintain high governance standards and deliver value to shareholders and consumers.
Vitalist is a technology provider that builds an ecosystem of connected health devices. Its core product, VitalOS™, enables brands to create seamlessly connected devices and applications that adapt to each user. The company’s recent acquisition of Somatix, a medical‑technology firm that specializes in AI‑powered remote patient monitoring, expands VitalOS’s reach into clinical and medical‑grade applications.
The Somatix acquisition was announced on March 31, 2026, and was described as a strategic move to add medical‑grade artificial intelligence and remote patient monitoring to VitalOS. The integration of Somatix’s SafeBeing™ platform, which analyzes activities of daily living in real time, is intended to deepen Vitalist’s presence in the personalized wellness and longevity technology markets.
Vitalist’s board now includes Natale, whose role is to represent Hantz Group’s interests following the acquisition. Hantz Group, founded by John Hantz, offers a range of financial services including banking, insurance, and financial planning. The company’s involvement signals a partnership that extends beyond the acquisition, potentially providing capital and advisory support.
The press release, issued through Globe Newswire, includes a forward‑looking statement disclaimer. It notes that the company’s statements about entering the remote patient monitoring channel, strategic growth, market positioning, and the integration of Somatix are based on assumptions that may not materialize. The release cautions readers not to place undue reliance on these forward‑looking statements and indicates that the company may not update or revise them unless required by securities law.
Vitalist’s stock is listed on the TSX Venture Exchange under the ticker VITA.V and on the OTCQB market under VTLSF. The company’s website, www.vitalist.ca, provides additional investor information, and a distribution list can be joined at www.vitalist.co/investors.
The appointment of Antonio Natale follows a series of corporate actions that have positioned Vitalist at an inflection point in the wearable technology and personalized wellness landscape. The company’s strategy now includes a broader portfolio that spans consumer wearables, enterprise solutions, and clinical monitoring, supported by the integration of Somatix’s AI analytics.
As Vitalist moves forward, the board’s composition and the addition of a director with a strong financial advisory background may influence the company’s governance and capital‑market strategy. Investors will likely monitor how the integration of Somatix’s technology and the support from Hantz Group affect the company’s product roadmap, revenue mix, and market expansion plans.
The press release does not constitute an offer to sell or a solicitation to buy securities in the United States, and the securities described are not registered under the U.S. Securities Act of 1933. The release also states that the TSX Venture Exchange does not accept responsibility for the accuracy of the information provided.
Vitalist’s next public disclosures, including its upcoming earnings report, will likely provide further insight into the financial impact of the Somatix acquisition and the role of the new board member. The company’s focus on integrating medical‑grade AI and remote patient monitoring into its existing wearable platform positions it to compete in a rapidly evolving consumer health market.
The appointment of Antonio Natale represents a strategic alignment of Vitalist’s growth objectives with the financial expertise of Hantz Group, reinforcing the company’s commitment to expanding its connected health ecosystem while maintaining strong governance and financial oversight.
Vitalist’s CEO, Kalvie Legat, said the new director “reflects the continued integration of Somatix into Vitalist and the strategic importance of Hantz Group’s support as we advance our vision for the future of connected health.” Legat added that Natale’s background in financial advisory, capital markets, and corporate planning will strengthen the board’s financial oversight and governance.
Natale, in a statement released with the announcement, said he is “deeply passionate about the potential of smart wearables to transform personal health” and that he looks forward to working with Legat and the rest of the board to maintain high governance standards and deliver value to shareholders and consumers.
Vitalist is a technology provider that builds an ecosystem of connected health devices. Its core product, VitalOS™, enables brands to create seamlessly connected devices and applications that adapt to each user. The company’s recent acquisition of Somatix, a medical‑technology firm that specializes in AI‑powered remote patient monitoring, expands VitalOS’s reach into clinical and medical‑grade applications.
The Somatix acquisition was announced on March 31, 2026, and was described as a strategic move to add medical‑grade artificial intelligence and remote patient monitoring to VitalOS. The integration of Somatix’s SafeBeing™ platform, which analyzes activities of daily living in real time, is intended to deepen Vitalist’s presence in the personalized wellness and longevity technology markets.
Vitalist’s board now includes Natale, whose role is to represent Hantz Group’s interests following the acquisition. Hantz Group, founded by John Hantz, offers a range of financial services including banking, insurance, and financial planning. The company’s involvement signals a partnership that extends beyond the acquisition, potentially providing capital and advisory support.
The press release, issued through Globe Newswire, includes a forward‑looking statement disclaimer. It notes that the company’s statements about entering the remote patient monitoring channel, strategic growth, market positioning, and the integration of Somatix are based on assumptions that may not materialize. The release cautions readers not to place undue reliance on these forward‑looking statements and indicates that the company may not update or revise them unless required by securities law.
Vitalist’s stock is listed on the TSX Venture Exchange under the ticker VITA.V and on the OTCQB market under VTLSF. The company’s website, www.vitalist.ca, provides additional investor information, and a distribution list can be joined at www.vitalist.co/investors.
The appointment of Antonio Natale follows a series of corporate actions that have positioned Vitalist at an inflection point in the wearable technology and personalized wellness landscape. The company’s strategy now includes a broader portfolio that spans consumer wearables, enterprise solutions, and clinical monitoring, supported by the integration of Somatix’s AI analytics.
As Vitalist moves forward, the board’s composition and the addition of a director with a strong financial advisory background may influence the company’s governance and capital‑market strategy. Investors will likely monitor how the integration of Somatix’s technology and the support from Hantz Group affect the company’s product roadmap, revenue mix, and market expansion plans.
The press release does not constitute an offer to sell or a solicitation to buy securities in the United States, and the securities described are not registered under the U.S. Securities Act of 1933. The release also states that the TSX Venture Exchange does not accept responsibility for the accuracy of the information provided.
Vitalist’s next public disclosures, including its upcoming earnings report, will likely provide further insight into the financial impact of the Somatix acquisition and the role of the new board member. The company’s focus on integrating medical‑grade AI and remote patient monitoring into its existing wearable platform positions it to compete in a rapidly evolving consumer health market.
The appointment of Antonio Natale represents a strategic alignment of Vitalist’s growth objectives with the financial expertise of Hantz Group, reinforcing the company’s commitment to expanding its connected health ecosystem while maintaining strong governance and financial oversight.
